{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:24:30Z","timestamp":1786944270036,"version":"build-2736575974"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Synchronous multiple primary colorectal cancer (SMPCRC) is rare and often shows molecular heterogeneity between primary lesions. Treatment decisions are particularly challenging in complex scenarios involving multiple independent lesions, distant metastasis, and advanced age with intolerance to standard chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 77-year-old man presented with hematochezia and was diagnosed with four independent neoplastic lesions within three months: a primary rectal lesion (pT3N1aM0), a sigmoid colon primary carcinoma, a proximal rectal adenoma with focal intramucosal carcinoma, and an adenocarcinoma of the transverse colon near the splenic flexure [resected by endoscopic submucosal dissection (ESD) three months later]. Bilateral hepatic metastases were detected six months postoperatively, with the carcinoembryonic antigen (CEA) level still within the reference range at diagnosis. Molecular testing of the two primary carcinomas revealed marked discordance: the primary rectal lesion carried mutation signals in both KRAS exon 4 and NRAS exon 2, whereas the sigmoid colon lesion was entirely RAS\/RAF\/PIK3CA wild-type \u2014 testing either lesion alone would have led to opposite anti-EGFR treatment decisions. Given the patient's advanced age and intolerance to standard chemotherapy, a staged, multimodal integrated strategy was adopted: synchronous surgery for three primary lesions, minimally invasive ESD of the transverse colon lesion, artificial ascites-assisted percutaneous microwave ablation (AA-MWA) for liver metastases, and individualized adjustment of chemotherapy (switched from CAPEOX to oxaliplatin plus raltitrexed because of intolerance). Over 18 months of follow-up, no radiological recurrence was observed and the patient remained in good general condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case demonstrates that primary lesions in SMPCRC can harbor substantial molecular heterogeneity, such that single-lesion testing may be insufficient to guide treatment decisions in complex scenarios. For elderly patients intolerant to standard regimens, a staged, multimodal integrated approach (synchronous surgery\u2009+\u2009ESD\u2009+\u2009AA-MWA\u2009+\u2009individualized chemotherapy adjustment) may serve as a feasible comprehensive treatment option.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1884577","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:33:35Z","timestamp":1786941215000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Synchronous multiple primary colorectal cancer with discordant RAS status between primary lesions: a case report in an elderly patient"],"prefix":"10.3389","volume":"13","author":[{"given":"Junting","family":"Guan","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqi","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","first-page":"1358","article-title":"Multiple primary malignant tumors: a survey of the literature and a statistical study","volume":"16","author":"Warren","year":"1932","journal-title":"Am J Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.3748\/wjg.v20.i22.6815","article-title":"Synchronous colorectal cancer: clinical, pathological and molecular implications","volume":"20","author":"Lam","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.canep.2010.12.007","article-title":"Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study","volume":"35","author":"Mulder","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"B6","year":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.18632\/oncoscience.118","article-title":"RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions","volume":"2","author":"de Macedo","year":"2015","journal-title":"Oncoscience"},{"key":"B8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/diagnostics11020314","article-title":"Synchronous colorectal cancer: improving accuracy of detection and analyzing molecular heterogeneity-the main keys for optimal approach","volume":"11","author":"Simu","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/annonc\/mdu378","article-title":"Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials","volume":"26","author":"Sorich","year":"2015","journal-title":"Ann Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"18678","DOI":"10.1038\/srep18678","article-title":"Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"863639","DOI":"10.3389\/fonc.2022.863639","article-title":"Concurrent RAS and RAS\/BRAF V600E variants in colorectal cancer: more frequent than expected? A case report","volume":"12","author":"Zelli","year":"2022","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijsu.2015.11.065","article-title":"The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence - a systematic review","volume":"25","author":"S\u00f8rensen","year":"2016","journal-title":"Int J Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1001\/jama.2010.1535","article-title":"Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab","volume":"304","author":"De Roock","year":"2010","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ijc.28955","article-title":"Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer","volume":"136","author":"Schirripa","year":"2015","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1136\/jclinpath-2015-203205","article-title":"Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas: comment on Li et al. (2015)","volume":"68","author":"Malapelle","year":"2015","journal-title":"J Clin Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.5301\/ijbm.5000273","article-title":"Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology?","volume":"32","author":"De Stefano","year":"2017","journal-title":"Int J Biol Markers"},{"key":"B19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4143\/crt.2024.947","article-title":"Molecular mosaics: unveiling heterogeneity in synchronous colorectal cancers","volume":"58","author":"Lee","year":"2026","journal-title":"Cancer Res Treat"},{"key":"B20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/modpathol.3880024","article-title":"Discordance of p53 mutations of synchronous colorectal carcinomas","volume":"13","author":"Eguchi","year":"2000","journal-title":"Mod Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrc.2017.102","article-title":"An evolutionary perspective on field cancerization","volume":"18","author":"Curtius","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng.3214","article-title":"A big bang model of human colorectal tumor growth","volume":"47","author":"Sottoriva","year":"2015","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/annonc\/mdu253","article-title":"Treatment of colorectal cancer in older patients: international society of geriatric oncology (SIOG) consensus recommendations 2013","volume":"26","author":"Papamichael","year":"2015","journal-title":"Ann Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/02656736.2014.891765","article-title":"Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract","volume":"30","author":"Zhang","year":"2014","journal-title":"Int J Hyperthermia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1007\/s00330-009-1463-x","article-title":"Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients","volume":"19","author":"Song","year":"2009","journal-title":"Eur Radiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1517\/14740338.2014.845167","article-title":"Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed","volume":"13","author":"Avallone","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"B29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/cpt.911","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update","volume":"103","author":"Amstutz","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1200\/JCO.2011.38.2994","article-title":"Comparative genomic analysis of primary versus metastatic colorectal carcinomas","volume":"30","author":"Vakiani","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1884577\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:33:43Z","timestamp":1786941223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1884577\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":30,"alternative-id":["10.3389\/fsurg.2026.1884577"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1884577","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"1884577"}}